How and Why Medical Affairs Can Support Diversity in Clinical Trials

In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the importance of patient-centric approaches. The speakers delve into the strategic roles of MSLs in education and the historical context of diversity in clinical trials. They provide actionable strategies for field medical teams to enhance trial diversity and emphasize the significance of cultural awareness and allyship. The episode concludes with reflections and a call to action for promoting diversity in medical settings.

Christina Wright, Brad Atkinson and Brian Wilson discuss the important role Medical Affairs/MSLs can play in supporting diversity in clinical trials

The group discusses…

👉 Why does medical affairs need to be involved in diversity clinical trial initiatives?

👉 How can field medical get comfortable with the D and I conversation?

👉 What resources can be helpful

👉 3 Pillars of “Allyship”

👉 Why insights are currency

The podcast is available through the links below: 

️ 〰️Spotify: https://lnkd.in/dRrSEyn 

️ 〰️Apple: https://lnkd.in/egSthAz 

️ 〰️Stitcher: https://lnkd.in/eqB-2wb 

📣 Now on YouTube 📣

Please subscribe: https://www.youtube.com/channel/UCS7XTUuk1XF5Tm5InADY6cA 

📣 Now on Instagram 📣

Please subscribe: 

https://www.instagram.com/msl_talk_podcast/ 

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions.

#msl #medicalaffairs #medicalscienceliaison #aspiringmsl #MSLTalk

(0:00) Introduction by Tom Caravela
(0:45) Guest introductions and topic overview
(3:26) Importance of diversity in FDA guidance on clinical trials
(9:06) MSL roles in therapeutic areas and diversity challenges
(11:37) Advancing science with patient centricity and overcoming barriers
(18:01) MSL strategic roles in education and historical context
(23:17) Actionable items for field medical teams to increase trial diversity
(27:22) Disease understanding and education in diverse populations
(29:16) Cultural awareness, unconscious bias, and allyship
(32:39) Diversity considerations in corporate and medical settings
(34:23) Final thoughts and actionable items on diversity
(37:00) Closing remarks and reflections
(41:26) Outro and call to action